Skip to main content
. Author manuscript; available in PMC: 2021 Jan 1.
Published in final edited form as: Dig Dis Sci. 2019 Aug 1;65(1):111–118. doi: 10.1007/s10620-019-05754-9

Table 4:

Adherence to ASGE inflammatory bowel disease surveillance guidelines8 amongst patients with inflammatory bowel disease

History Surveillance colonoscopies within ASGE guidelines – Proportion (%)
≥ 8 years of left-sided or extensive disease (without additional high-risk features) 3/3 (100.0)
Primary Sclerosing Cholangitis 1/1 (100.0)
Active inflammation 2/12 (16. 7)
History of dysplasia within the past 5 years 1/5 (20.0)
Family history of colorectal cancer in first-degree relative < 50 0/2 (0.0)
Multiple pseudopolyps 1/3 (33.3)
Stricture 1/1 (100.0)